Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management)
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective The impact of individual antiarrhythmic drugs (AADs) on mortality and hospitalization in atrial fibrillation (AF) was evaluated Background Cardiovascular (CV) outcomes in AF patients on pharmacologic rhythm control therapy have not been compared with rate control therapy based on AAD selection. Methods We compared CV outcomes in the AFFIRM trial in subgroups defined by the initial AAD selected with propensity score matched subgroups from the rate arm (Rate). Results 729 amiodarone patients, 606 sotalol patients & 268 class 1C patients were matched. The composite outcome of mortality or CV hospitalizations (CVH) showed better outcomes with Rate compared to amiodarone (Hazard Ratio [HR] 1.18, 95% confidence intervals {CI}:1.03–1.36, p=0.02), sotalol (HR=1.32, CI: 1.13–1.54, p<0.001) and class 1C (HR=1.22, CI: 0.97–1.56, p=0.10). There was a non-significant increase in mortality with amiodarone (HR=1.20, CI: 0.94–1.53, p=0.15) with the risk of non-CV death, being significantly higher with amiodarone versus Rate. (HR=1.11, CI: 1.01–1.24, p=0.04). First CVH event rates at 3 years were 47% for amiodarone, 50% for sotalol and 44% for class 1C versus 40%, 40% and 36% respectively for Rate (amiodarone HR=1.20,CI:1.03–1.40,p=0.02, sotalol HR=1.364, CI:1.16–1.611, p<0.001, class 1C HR=1.24,CI:0.96–1.60,p=0.09). Time to CVH with intensive care unit stay (ICUH) or death was shorter with amiodarone (HR=1.22, CI: 1.02–1.46, p=0.03). Conclusions In AFFIRM, composite mortality and CVH outcomes differed for Rate and AADs due to differences in CVH; CVH event rates during follow-up were high for all cohorts, but they were higher for all groups on AADs. Death, ICUH and non-CV death were more frequent with amiodarone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Wilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E. G., Calkins, H., Hall, B., et al. (2010) · JAMA · doi:10.1001/jama.2009.2029 · Cited by 1,170 · cited 1×
“However, such an analysis is still relevant and potentially informative, because most of these agents are currently in widespread clinical use and still employed in clinical trials (15,16).”
BackgroundSelf-citationWazni, O. M., Marrouche, N. F., Martin, D. O., Verma, A., Bhargava, M., Saliba, W., Bash, D., Schweikert, R., Brachmann, J., Gunther, J., et al. (2005) · JAMA · doi:10.1001/jama.293.21.2634 · Cited by 1,121
Cited by
Chung, M. K., Eckhardt, L. L., Chen, L. Y., Ahmed, H. M., Gopinathannair, R., Joglar, J. A., Noseworthy, P. A., Pack, Q. R., Sanders, P., Trulock, K. M., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000748 · Cited by 537
Steinberg, B. A., Hellkamp, A. S., Lokhnygina, Y., Patel, M. R., Breithardt, G., Hankey, G. J., Becker, R. C., Singer, D. E., Halperin, J. L., Hacke, W., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu359 · Cited by 356
Freemantle, N., Marston, L., Walters, K., Wood, J., Reynolds, M. R., & Petersen, I. (2013) · BMJ · doi:10.1136/bmj.f6409 · Cited by 211
Self-citationHakalahti, A., Biancari, F., Nielsen, J. C., & Raatikainen, M. J. P. (2015) · Europace · doi:10.1093/europace/euu376 · Cited by 191
“cantly lower during a 5 years follow-up in the rate-control arm compared with the AAD arm.(35) Hence, long-term AAD use requires repeated evaluation and careful follow-up of the”
BackgroundGallego, P., Roldan, V., Marín, F., Romera, M., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0556 · Cited by 187
Metadata
- Authors
- Saksena, S., Slee, A., Waldo, A. L., Freemantle, N., Reynolds, M., Rosenberg, Y., Rathod, S., Grant, S., Thomas, E., & Wyse, D. G.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 58
- Issue
- 19
- Pages
- 1975-1985
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W401238
- Cited by
- 135
- References
- 4
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). https://app.cochat.ai/papers/10.1016/j.jacc.2011.07.036
- The paper
- Saksena, S., Slee, A., Waldo, A. L., Freemantle, N., Reynolds, M., Rosenberg, Y., Rathod, S., Grant, S., Thomas, E., & Wyse, D. G. (2011). Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2011.07.036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.